A Complete Patient's Guide to Endoscopic Ultrasound (EUS) in Nigeria
Table of Contents
If your doctor has recommended an Endoscopic Ultrasound (EUS) or you are seeking answers about unexplained abdominal symptoms, this guide explains everything you need to know. This includes what EUS is, why it is performed, what to expect, and what makes it one of the most precise diagnostic tools available in gastroenterology today.
At Redus Center for Digestive Health in Lagos, our specialists use EUS to evaluate and diagnose a wide range of digestive, pancreatic, and biliary conditions with exceptional accuracy.
What is Endoscopic Ultrasound (EUS)?
Endoscopic Ultrasound (EUS) is a minimally invasive procedure that combines two well-established medical technologies — endoscopy and ultrasound — into a single, highly informative examination. It allows doctors to obtain detailed images of the digestive tract and surrounding organs, including the pancreas, liver, and lymph nodes.
A thin, flexible tube called an echoendoscope is passed through the mouth or, less commonly, the rectum. At the tip of this instrument is both a small video camera and a high-frequency ultrasound transducer.
Unlike conventional external (transabdominal) ultrasound, where sound waves must travel through the skin and layers of tissue and fat, EUS places the ultrasound probe directly adjacent to the organ of interest from inside the digestive tract. This dramatically reduces the distance between the probe and the target, producing images of far greater resolution and detail — often revealing structures and lesions that other imaging methods cannot detect.
EUS is commonly used to diagnose and assess various conditions affecting the gastrointestinal system. It can also be combined with therapeutic interventions such as fine needle aspiration (FNA) biopsy, fluid drainage, or coeliac plexus nerve block, making it a remarkably versatile tool in modern gastroenterology.
How EUS Differs From Other Imaging Technologies
Many patients are familiar with CT scans, MRI, and conventional ultrasound. Understanding how EUS compares helps clarify why it is often the preferred choice for certain conditions:
- Conventional (Transabdominal) Ultrasound: Performed externally on the abdomen. Good for visualising the liver, gallbladder, and kidneys, but limited by body habitus, bowel gas, and distance from deep structures like the pancreas. Cannot guide biopsies of deep lesions reliably.
- CT Scan: Excellent for detecting masses, lymph node enlargement, and distant metastases, and is often the first-line investigation. However, CT has limited resolution for small lesions in the pancreas or bile ducts, and cannot obtain tissue samples.
MRI / MRCP: Provides excellent soft tissue contrast and detailed duct imaging without radiation. Preferred for non-invasive bile duct assessment. However, it cannot biopsy lesions or drain fluid.
EUS: Provides the highest resolution imaging of the pancreas, bile ducts, stomach wall, oesophagus, and surrounding lymph nodes. Can simultaneously obtain biopsies, drain cysts, or deliver targeted therapies. It is the gold standard for staging upper gastrointestinal cancers and evaluating pancreatic lesions.
Why is EUS Performed?
EUS is recommended across a broad range of clinical situations. At Redus Center for Digestive Health, our gastroenterologists may recommend EUS for the following purposes:
EUS is recommended across a broad range of clinical situations. At Redus Center for Digestive Health, our gastroenterologists may recommend EUS for the following purposes:
Staging of Gastrointestinal Cancers
One of the most important roles of EUS is the staging of cancers along the digestive tract. EUS can assess the depth of tumour invasion through the wall of the oesophagus, stomach, rectum, or duodenum (T-staging), and evaluate nearby lymph nodes for involvement (N-staging). This information is critical for determining whether surgery, chemotherapy, radiotherapy, or a combination approach is the best treatment plan.EUS is particularly valuable in staging cancer of the oesophagus, stomach, pancreas, ampulla of Vater, and rectum.
Evaluation of Pancreatic Lesions
The pancreas sits deep in the abdomen, behind the stomach — which makes it the ideal organ to examine via EUS. The procedure can detect pancreatic tumours, cysts, and inflammatory masses with far greater clarity than CT or external ultrasound. EUS-guided Fine Needle Aspiration (EUS-FNA) allows tissue to be sampled directly from a pancreatic lesion under real-time imaging guidance, enabling a definitive tissue diagnosis without surgery.
Investigation of Pancreatic Cysts
Pancreatic cysts are increasingly detected incidentally on CT or MRI scans. Not all cysts are dangerous, but some carry a risk of malignant transformation. EUS provides detailed imaging of cyst morphology — size, wall thickness, internal septa, and the presence of solid components — and EUS-FNA allows cyst fluid to be aspirated and analysed to assess the risk of cancer.
Diagnosis and Assessment of Chronic Pancreatitis
Chronic pancreatitis involves progressive inflammation and scarring of the pancreas, often causing persistent pain, malabsorption, and diabetes. EUS is one of the most sensitive tests for detecting early changes of chronic pancreatitis — including ductal dilation, calcifications, and parenchymal changes — even before they become apparent on CT or MRI.
Bile Duct Stones and Biliary Assessment
EUS is highly sensitive for detecting small stones in the common bile duct (choledocholithiasis) that may be missed by conventional ultrasound or even CT. When a patient presents with jaundice, abnormal liver function tests, or biliary pain, EUS can confirm or exclude bile duct stones before proceeding to ERCP, avoiding unnecessary intervention.
Evaluation of Submucosal Lesions
Submucosal lesions are abnormal growths that lie beneath the inner lining (mucosa) of the digestive tract. They are often discovered incidentally during a standard upper endoscopy. EUS can determine the layer of the gut wall from which the lesion arises, its echotexture, and its size — all of which help determine whether it is benign (such as a lipoma or leiomyoma) or potentially malignant (such as a gastrointestinal stromal tumour, or GIST). EUS-guided biopsy can confirm the diagnosis.
Mediastinal and Lung Staging
Through the oesophageal wall, EUS can image and biopsy lymph nodes and masses in the mediastinum (the central chest cavity). This is particularly useful in staging lung cancer and lymphoma, and for evaluating unexplained mediastinal masses.
Assessment of Rectal and Anal Conditions
Using a rectal approach, EUS is used to evaluate the layers of the rectal wall in patients with rectal cancer, helping determine whether surgery can be sphincter-preserving. It is also used to assess anal sphincter integrity in patients with faecal incontinence, identify perianal fistulae and abscesses, and evaluate local recurrence after rectal cancer surgery.
Unexplained Abdominal Pain
When patients present with persistent or recurrent upper abdominal pain and other investigations have been unrevealing, EUS can provide a more detailed evaluation of the pancreas, bile ducts, stomach wall, and surrounding structures that may identify an underlying cause.
Portal Hypertension and Oesophageal Varices
EUS can assess the severity of portal hypertension by imaging para-oesophageal and perforating veins, and can complement standard endoscopy in managing patients with oesophageal varices.
EUS-Guided Fine Needle Aspiration (EUS-FNA) and Biopsy
One of the most transformative capabilities of EUS is its ability to obtain tissue samples from deep-seated lesions under real-time imaging guidance. This technique — called EUS-guided Fine Needle Aspiration (EUS-FNA) or, using a slightly larger needle, EUS-guided Fine Needle Biopsy (EUS-FNB) — allows the endoscopist to pass a thin needle through the wall of the oesophagus, stomach, or duodenum and directly into a lesion in the pancreas, liver, lymph node, or other adjacent structure.
The key advantages of EUS-FNA/FNB include:
- High accuracy: EUS-FNA achieves diagnostic accuracy of over 85% for pancreatic masses, significantly reducing the need for diagnostic surgery.
- Safety: Because the needle path is short and precisely guided, complication rates are very low.
- Real-time guidance: The operator watches the needle enter the lesion on the ultrasound image, ensuring the correct area is sampled.
- Versatility: Tissue can be sampled from the pancreas, lymph nodes, liver, adrenal glands, mediastinal masses, and submucosal lesions.
Samples obtained are sent to a pathologist for cytological or histological analysis, and results are typically available within a few days to a week.
Therapeutic Uses of EUS
EUS has evolved well beyond diagnosis and biopsy. A growing number of therapeutic procedures can now be performed through the echoendoscope, including:
EUS-Guided Drainage of Pancreatic Pseudocysts and Walled-Off Necrosis
Pancreatic pseudocysts are fluid collections that can develop as a complication of acute pancreatitis. When large or symptomatic, they can be drained under EUS guidance by creating a channel between the cyst and the stomach or duodenum, allowing the fluid to drain internally without the need for surgery.
Coeliac Plexus Neurolysis and Block
Severe pain from pancreatic cancer or chronic pancreatitis is often difficult to control with standard medications. EUS allows the precise injection of anaesthetic or neurolytic agents into the coeliac plexus — the nerve cluster behind the pancreas responsible for transmitting pain signals from the upper abdomen — providing significant and lasting pain relief for many patients.
EUS-Guided Billiary Drainage
In patients in whom ERCP is technically not possible (for example, due to surgically altered anatomy or a tumour obstructing the bile duct), EUS can be used to access the bile duct from inside the stomach or duodenum and create a drainage channel, either directly into the bowel (choledochoduodenostomy or hepaticogastrostomy) or to allow ERCP to proceed from a different approach.
EUS-Guided Tumor Ablation
Emerging techniques allow EUS to guide the delivery of ablative energy (such as radiofrequency ablation) directly into small pancreatic tumours or metastases, offering a minimally invasive treatment option for selected patients.
Preparing for Your EUS at Redus Health
Proper preparation is important for a safe and successful EUS procedure. Your care team will provide detailed personalised instructions, but the following general guidelines apply:
Fasting
You will be asked to fast for at least 6 to 8 hours before the procedure. This ensures the upper digestive tract is clear, allowing the endoscopist an unobstructed view and reducing the risk of aspiration during sedation. If you are having a rectal EUS, bowel preparation (a laxative or enema) may be required instead.
Medication Review
Inform your gastroenterologist about all medications you take, with particular attention to:
- Blood-thinning medications (anticoagulants and antiplatelets such as warfarin, clopidogrel, and aspirin): These may need to be paused before the procedure, particularly if a biopsy is planned, to reduce bleeding risk.
- Diabetes medications: Fasting requirements mean your insulin or oral hypoglycaemics may need to be adjusted on the day of the procedure.
- NSAIDs and other medications: Your doctor will review these on an individual basis.
Allergies and Medical History
Inform your doctor of any known allergies, particularly to sedatives or latex. Also disclose any significant medical history, including heart or lung conditions, previous GI surgeries, or prior adverse reactions to anaesthesia or sedation.
Arranging Transport
Because you will receive sedation during the procedure, you will not be able to drive or travel unaccompanied after EUS. Please arrange for a responsible adult to accompany you and take you home. Plan to rest for the remainder of the day.
What to Expect During the EUS Procedure
Arrival and Pre-Procedure Assessment
On arrival at Redus Center for Digestive Health, you will be greeted by our nursing team who will complete a pre-procedure health assessment, check your vital signs, confirm your consent, and place an intravenous (IV) cannula for medication delivery. You will change into a hospital gown and be prepared for sedation.
Sedation
EUS is performed under conscious or deep sedation, meaning you will be deeply relaxed and drowsy throughout the procedure and will have little or no memory of it afterwards. For upper EUS, a local anaesthetic throat spray is also applied to minimise the gag reflex and improve your comfort.
Upper EUS Procedure
For an upper EUS, you will be positioned lying on your left side. The echoendoscope is gently passed through your mouth, down the oesophagus, and into the stomach and duodenum. The physician systematically examines the walls of the oesophagus, stomach, and duodenum, as well as adjacent structures including the pancreas, bile ducts, liver, gallbladder, spleen, and surrounding lymph nodes. The ultrasound images are interpreted in real time, and any additional interventions such as biopsy are performed as indicated.
Rectal EUS
For a lower EUS, you will be positioned on your left side or back. The echoendoscope is gently introduced through the rectum and advanced to examine the rectal wall, anal sphincter, and surrounding pelvic structures. This is typically used for rectal cancer staging, anal sphincter assessment, or evaluation of perianal disease.
Procedure Duration
A diagnostic EUS typically takes 20 to 45 minutes. If EUS-FNA biopsy, cyst drainage, or other therapeutic interventions are performed, the procedure may take longer — typically 45 to 90 minutes in total. You should plan to spend approximately 2 to 3 hours at the centre, accounting for preparation and recovery.
Recovery and Post-Procedure Care
Immediate Recovery
Following the procedure, you will be monitored in the recovery area until the effects of sedation have fully worn off — typically 30 to 60 minutes. Nursing staff will monitor your vital signs, oxygen levels, and comfort throughout this period. You may experience mild bloating or a sensation of fullness from air introduced during the procedure, which typically resolves quickly.
Going Home
Most patients are discharged the same day. You must be collected and accompanied home by a responsible adult. You should not drive, operate machinery, drink alcohol, or make important decisions for the remainder of the day.
Diet and Activity
Your doctor will advise you on resuming eating and drinking. In most cases, you can start with light fluids and soft foods within a few hours and return to a normal diet the following day. Avoid strenuous physical activity for 24 hours.
Normal Side Effect
Some mild, short-lived effects are normal after EUS:
- Mild sore throat, usually resolves within 24 to 48 hours
- Mild bloating or gas, typically settles within a few hours
- Mild abdominal discomfort that may persist for a short time, especially if biopsy was performed
When To Seek Medical Attention
Contact Redus Health immediately or go to the nearest emergency facility if you experience any of the following after your EUS:
- Severe or worsening abdominal pain
- High fever or chills
- Persistent vomiting
- Signs of bleeding: black or tarry stools, blood in stool or vomit
- Difficulty swallowing or breathing
- Swelling of the neck (rare, may indicate perforation)
Risks and Complications of EUS
EUS is generally considered a very safe procedure with a low overall complication rate. However, as with any invasive procedure, risks exist and you should be fully informed before consenting.
Bleeding
The most common risk associated with EUS-FNA biopsy. Minor bleeding at the needle puncture site is common and usually resolves spontaneously. Significant bleeding requiring treatment is rare. Patients on anticoagulant or antiplatelet therapy are at higher risk, which is why these medications are typically paused beforehand.
Perforation
There is a very small risk of a tear or hole in the wall of the oesophagus, stomach, or duodenum during scope passage or manipulation. Perforation is uncommon but may require surgical repair if it occurs.
Infection
The most common risk associated with EUS-FNA biopsy. Minor bleeding at the needle puncture site is common and usually resolves spontaneously. Significant bleeding requiring treatment is rare. Patients on anticoagulant or antiplatelet therapy are at higher risk, which is why these medications are typically paused beforehand.
Pancreatitis
When FNA of the pancreas is performed, there is a small risk of triggering acute pancreatitis (inflammation of the pancreas), manifesting as abdominal pain after the procedure. This is usually mild and self-limiting, but in rare cases may require hospitalisation.
Reaction to Sedation
Adverse reactions to the sedative medications used are uncommon. Our team monitors you closely throughout the procedure and is fully equipped to respond to any reaction.
Tumor Seeding
There is a theoretical risk of spreading cancer cells along the needle track when biopsying a malignant lesion. The clinical significance of this is considered very low, and the benefits of obtaining a tissue diagnosis almost always far outweigh this risk in practice.
Your gastroenterologist will discuss all relevant risks with you before the procedure, tailor their approach to minimise them, and answer any questions you may have.
EUS Compared to Alternative Investigation
EUS is not always the first investigation ordered. It is typically used when other imaging has been inconclusive, when tissue sampling is needed, or when therapeutic intervention is required. The following comparison helps clarify when EUS is most appropriate:
- For detecting pancreatic lesions smaller than 2 cm: EUS is more sensitive than CT or MRI and is the preferred investigation when clinical suspicion is high despite normal cross-sectional imaging.
- For staging upper GI cancers: EUS is the most accurate method for local T and N staging, and is recommended before major surgery for oesophageal, gastric, and rectal cancers.
- For bile duct stones: EUS is highly accurate and can be used to confirm the diagnosis before proceeding to ERCP, avoiding unnecessary ERCP in patients who do not have stones.
- For submucosal lesions: EUS is the investigation of choice, providing information on the layer of origin, size, and features that guide management decisions.
For tissue diagnosis from deep lesions: EUS-FNA/FNB is the least invasive way to obtain a biopsy from the pancreas, lymph nodes, or mediastinum, avoiding surgery.
EUS At Redus Health
At Redus Center for Digestive Health, located in Lekki Phase 1, Lagos, we are proud to offer Endoscopic Ultrasound as part of our comprehensive suite of advanced endoscopic services. EUS remains one of the most technically demanding procedures in gastroenterology, requiring specialist training, expertise, and dedicated equipment, and we are committed to delivering this at the highest standard.
Our team of consultant gastroenterologists and endoscopic surgeons has extensive experience in both diagnostic and therapeutic EUS. We combine clinical excellence with a patient-centred approach, ensuring that every patient understands their procedure, feels supported throughout their care journey, and receives results that are communicated clearly and promptly.
We welcome referrals from physicians across Lagos and Nigeria, and are happy to see patients who wish to self-refer for an initial consultation.
Frequently Asked Questions about Endoscopic Ultrasound
Is EUS painful?
EUS is performed under sedation, so the vast majority of patients experience little to no pain or discomfort during the procedure. You may feel mild bloating or pressure, but this is generally well tolerated. Mild throat discomfort after upper EUS is common and settles within a day or two.
How long does EUS take?
A straightforward diagnostic EUS takes approximately 20 to 45 minutes. Procedures involving biopsy, drainage, or other therapeutic interventions take longer — up to 90 minutes. Including preparation and recovery, plan for approximately 2 to 3 hours at the centre in total.
How soon will I get my results?
Your gastroenterologist will be able to share preliminary imaging findings with you on the day of the procedure or shortly after. If a biopsy (EUS-FNA or FNB) was taken, pathology results typically take 3 to 7 working days, depending on the complexity of the analysis. A follow-up appointment will be arranged to discuss findings and next steps.
Can EUS detect cancer?
Yes. EUS is one of the most sensitive imaging tools for detecting cancers of the pancreas, oesophagus, stomach, bile ducts, and rectum. It can also accurately assess the local extent of a known cancer (staging), which directly influences treatment decisions. EUS-guided biopsy allows definitive tissue diagnosis in most cases.
Is EUS the same as an endoscopy?
EUS and standard endoscopy (gastroscopy) are related but different procedures. A standard upper endoscopy uses a forward-viewing camera to examine the lining of the oesophagus, stomach, and duodenum. EUS uses a side-viewing scope with an ultrasound probe at the tip to image the layers of the gut wall and the organs beyond it. EUS provides a much more detailed view but requires additional expertise and equipment.
Will I need EUS more than once?
This depends entirely on your clinical situation. Some patients require a single EUS to establish a diagnosis, while others may need follow-up procedures to monitor a known lesion (such as a pancreatic cyst) over time, assess treatment response, or guide repeat therapeutic interventions.
Is EUS available in Nigeria?
EUS has historically been a limited resource in sub-Saharan Africa. At Redus Center for Digestive Health, we are proud to offer this advanced procedure in Lagos, giving patients access to world-class diagnostic technology without the need to travel abroad.
Book Your EUS Consultation at Redus Health
If you have been referred for an Endoscopic Ultrasound, or if you are experiencing symptoms such as unexplained abdominal pain, unintentional weight loss, jaundice, or have been told you have a lesion requiring further assessment, we encourage you to contact our team at Redus.
Our specialists will review your history and existing investigations, advise whether EUS is the most appropriate next step, and guide you through every aspect of your care with clarity and compassion.
Copyright © 2025 Redus All Rights Reserved.